Qianliu Cheng

Title: Innovations of Qianliu Cheng in Pharmaceutical Development

Introduction

Qianliu Cheng is a notable inventor based in Hefei, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work focuses on enhancing drug efficacy and reducing adverse effects through novel chemical compositions.

Latest Patents

Qianliu Cheng holds a patent for a "Memantine paroxetine cocrystal salt and its preparation method, pharmaceutical composition and application." This invention provides a cocrystal salt of memantine paroxetine sulfate hydrate. The mechanism of action involves being a 5-HT inhibitor and NMDA receptor antagonist, making it a multi-target drug. Preliminary pharmacokinetic experiments have shown that the cocrystal salt significantly improves drug absorption, blood drug concentration, bioavailability, and curative effect. This advancement offers a material basis for reducing dosage and minimizing adverse drug reactions.

Career Highlights

Cheng is associated with Hefei Keda Bio-technology Co. Ltd., where he continues to innovate in the pharmaceutical sector. His research has the potential to lead to more effective treatments and improved patient outcomes.

Collaborations

Cheng collaborates with notable colleagues, including Ke Wang and Zonggui Wang, to further enhance the impact of his research and inventions.

Conclusion

Qianliu Cheng's contributions to pharmaceutical innovations exemplify the importance of research in developing effective drug therapies. His work not only advances scientific knowledge but also holds promise for improving patient care through innovative drug formulations.